Search results for: %eb%a0%88%eb%b9%84%ed%8a%b8%eb%9d%bc-%eb%b9%84%ec%95%84%ea%b7%b8%eb%9d%bc-%ec%b0%a8%ec%9d%b4

ASX soon to get its first erectile dysfunction company

This is one company that probably won’t get a limp reception from the market. Brisbane-based LTR Pharma on Friday opened its $7 million initial public offering to fund its planned launch of a fast-acting treatment for erectile dysfunction. LTR’s SPONTAN nasal spray takes effect in just 10 minutes – far faster than Viagra and similar

Read more